GlaxoSmithKline Pharma looks to launch 2-3 combination vaccines in India: Report

30 Mar 2016 Evaluate

GlaxoSmithKline Pharmaceuticals is reportedly looking at launching two or three combination vaccines in India in the near future, to address a host of paediatric disease. The company is also organizing programmes to spread awareness about the need of vaccination among public.

The company is expected to launch a four-antigen, a five-antigen and a six-antigen combination to cover several disease in a single vaccine. Various paediatric disease vaccinations including diphtheria, pertussis (whooping cough), and tetanus (DPT), Hepatitis B and Polio are to be addressed through these combinations.

GlaxoSmithKline Pharmaceuticals is a subsidiary of GlaxoSmithKline plc, one of the world's leading research-based pharmaceutical and healthcare companies, committed to improving the quality of human life by enabling people to do more, feel better and live longer.

 

Glaxosmithkline Phar Share Price

2280.00 -49.60 (-2.13%)
20-Jan-2026 14:12 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.15
Dr. Reddys Lab 1175.25
Cipla 1380.40
Zydus Lifesciences 876.45
Lupin 2170.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×